Culture

“Culture eats strategy for breakfast” – Peter Drucker

About Us

 
Zentrela is led by a team of Canadian scientists from the fields of neuroscience and artificial intelligence.
 
  • Proven technology platform validated in peer-reviewed scientific journals
  • Seed funding from Jornic Ventures and the Ontario Brain Institute
  • Early-stage revenue traction with LPs
  • Patented IP
  • Scalable research methodology to meet the demands of the cannabis market
researcher gathering cognalyzer data from study participant
zentrela headquarters

History


Zentrela was founded in 2016 by Israel Gasperin when he combined his fascination with brainwave analysis and his business observation that every facet of the exploding cannabis sector was going to need access to objective product effect data.
 
Israel was joined by Dr. Dan Bosnyak, a neuroscientist at McMaster University, and together they established the foundations of Zentrela, a neurotechnology pioneer using AI to analyze EEG data in pursuit of the world’s largest database of cannabis psychoactive effects.

Values


At our core, Zentrela is a scientific organization. We serve our customers best when we have done our research, followed the data and made sense of the world. These are the values we prize above others:
 
  1. Objectivity – a dedication to rational and empirical inquiry.
  2. Curiosity – find out what is revealed by the data.
  3. Honesty – the principal value that underpins all scientific inquiry.
  4. Accountability – we stand behind our work and our commitments to each other and to our clients.
 

Leadership Team

Israel Gasperin

Founder & CEO

Roy Agostino

Chief Commercial Officer

Dr. Dan Bosnyak

Chief Scientific Officer

Upmanyu Sharma

Director of Lab Operations

Strategic Advisory Board

Alex Revich

Equity Partner at Hybrid Pharm

Jay McMillan

CEO at UberGreen

Gregg Battersby

Founder and President at Peak Processing

Andrew Holden

Co-founder & CTO at Weever Apps

Jordon Sansom

Partner at Jornic Ventures